- call +1-201-465-4211
- email sales@mrinsights.biz
Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.
Scope of the Report:
The global Cox-2 Inhibitors market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cox-2 Inhibitors.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cox-2 Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cox-2 Inhibitors market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cox-2 Inhibitors Market Overview
1.1 Product Overview and Scope of Cox-2 Inhibitors
1.2 Classification of Cox-2 Inhibitors by Types
1.2.1 Global Cox-2 Inhibitors Revenue Comparison by Types (2019-2024)
1.2.2 Global Cox-2 Inhibitors Revenue Market Share by Types in 2018
1.2.3 Selective Cox-2 Inhibitors
1.2.4 Non Selective Cox-2 Inhibitors
1.3 Global Cox-2 Inhibitors Market by Application
1.3.1 Global Cox-2 Inhibitors Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Cox-2 Inhibitors Market by Regions
1.4.1 Global Cox-2 Inhibitors Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.5 Global Market Size of Cox-2 Inhibitors (2014-2024)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Cox-2 Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Cox-2 Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Cox-2 Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Cox-2 Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.5 Cadila Pharmaceuticals
2.5.1 Business Overview
2.5.2 Cox-2 Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cadila Pharmaceuticals Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sabinsa Corporation
2.6.1 Business Overview
2.6.2 Cox-2 Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sabinsa Corporation Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cox-2 Inhibitors Market Competition, by Players
3.1 Global Cox-2 Inhibitors Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cox-2 Inhibitors Players Market Share
3.2.2 Top 10 Cox-2 Inhibitors Players Market Share
3.3 Market Competition Trend
4 Global Cox-2 Inhibitors Market Size by Regions
4.1 Global Cox-2 Inhibitors Revenue and Market Share by Regions
4.2 North America Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.3 Europe Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.5 South America Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5 North America Cox-2 Inhibitors Revenue by Countries
5.1 North America Cox-2 Inhibitors Revenue by Countries (2014-2019)
5.2 USA Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5.3 Canada Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5.4 Mexico Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6 Europe Cox-2 Inhibitors Revenue by Countries
6.1 Europe Cox-2 Inhibitors Revenue by Countries (2014-2019)
6.2 Germany Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.3 UK Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.4 France Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.5 Russia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.6 Italy Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cox-2 Inhibitors Revenue by Countries
7.1 Asia-Pacific Cox-2 Inhibitors Revenue by Countries (2014-2019)
7.2 China Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.3 Japan Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.4 Korea Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.5 India Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8 South America Cox-2 Inhibitors Revenue by Countries
8.1 South America Cox-2 Inhibitors Revenue by Countries (2014-2019)
8.2 Brazil Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8.3 Argentina Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8.4 Colombia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cox-2 Inhibitors by Countries
9.1 Middle East and Africa Cox-2 Inhibitors Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.3 UAE Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.4 Egypt Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.6 South Africa Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
10 Global Cox-2 Inhibitors Market Segment by Type
10.1 Global Cox-2 Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 Global Cox-2 Inhibitors Market Forecast by Type (2019-2024)
10.3 Selective Cox-2 Inhibitors Revenue Growth Rate (2014-2024)
10.4 Non Selective Cox-2 Inhibitors Revenue Growth Rate (2014-2024)
11 Global Cox-2 Inhibitors Market Segment by Application
11.1 Global Cox-2 Inhibitors Revenue Market Share by Application (2014-2019)
11.2 Cox-2 Inhibitors Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Cox-2 Inhibitors Market Size Forecast (2019-2024)
12.1 Global Cox-2 Inhibitors Market Size Forecast (2019-2024)
12.2 Global Cox-2 Inhibitors Market Forecast by Regions (2019-2024)
12.3 North America Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.4 Europe Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.6 South America Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cox-2 Inhibitors Picture
Table Product Specifications of Cox-2 Inhibitors
Table Global Cox-2 Inhibitors and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
